Search Ontology:
ChEBI
alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc
- Term ID
- CHEBI:42528
- Synonyms
-
- 2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-beta-D-galactopyranose
- 2-(acetylamino)-3-O-[2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl]-2-deoxy-beta-D-galactopyranose
- 2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranose
- 2-acetamido-3-O-(2-acetamido-2-deoxy-alpha-D-galactopyranosyl)-2-deoxy-beta-D-galactopyranose
- alpha-D-GalNAc-(1->3)-beta-D-GalNAc
- alphaGalNAc(1->3)betaGalNAc
- beta-D-galactopyranose, 2-(acetylamino)-3-O-[2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl]-2-deoxy-
- FORSMANN ANTIGEN
- Forssman disaccharide
- GalNAca1-3GalNAcb
- N-acetyl-alpha-D-galactosaminyl-(1->3)-N-acetyl-beta-D-galactosamine
- WURCS=2.0/2,2,1/[a2112h-1b_1-5_2*NCC/3=O][a2112h-1a_1-5_2*NCC/3=O]/1-2/a3-b1
- Definition
- An alpha-D-GalpNAc-(1->3)-D-GalpNAc having beta-configuration at the reducing end anomeric centre.
- References
-
- GlyGen:G97834OQ
- GlyTouCan:G97834OQ
- PDBeChem:FSM
- PMID:17431391
- PMID:17652409
- PMID:19443021
- PMID:25568069
- PMID:2856907
- PMID:31537530
- PMID:3257757
- PMID:36988069
- PMID:6704310
- PMID:7521740
- PMID:7696844
- PMID:7696847
- PMID:7819593
- PMID:8125993
- PMID:9846499
- Reaxys:7800092
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Show first 5 Terms
Phenotype
Phenotype resulting from alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc
Phenotype where environments contain alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc
Phenotype modified by environments containing alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc
Human Disease Model